4//SEC Filing
ALLERGAN INC 4
Accession 0001127602-15-001286
CIK 0000850693operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:12 PM ET
Size
7.5 KB
Accession
0001127602-15-001286
Insider Transaction Report
Form 4
ALLERGAN INCAGN
Jones Trevor M
Director
Transactions
- Award
Phantom Stock Units
2014-12-11$211.14/sh+0.88$186→ 7,431.83 total→ Common Stock (0.88 underlying) - Award
Phantom Stock Units
2015-01-02$212.75/sh+70.5$14,999→ 7,502.33 total→ Common Stock (70.5 underlying)
Footnotes (4)
- [F1]Converts to common stock on a 1-for-1 basis.
- [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program for quarterly dividend, exempt transaction under Rule 16a-11.
- [F3]Phantom stock units are to be settled 100% in common stock upon the Reporting Person's retirement as an Allergan, Inc. director.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program for quarterly portion of annual retainer.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850693
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:12 PM ET
- Size
- 7.5 KB